Modified Orbital Decompression in the Treatment of Moderate-to-severe Grave's Ophthalmopathy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorSun Yat-sen University
About this trial
To investigate the efficacy and safety of modified deep lateral wall decompression and/or medial wall decompression for Moderate-to-severe Grave's Ophthalmopathy.
Eligibility criteria
Qualifiers
EUGOGO/NOSPECS grade was moderate-to-severe thyroid associate ophthalmopathy;
CAS≤3 score;
stable thyroid function for at least 6 months;
able and willing to participate in clinical trials and ensure regular follow-up;
Disqualifiers
any uncontrollable clinical problems (severe mental, neurological, cardiovascular, respiratory and other systemic diseases and malignant tumors);
B-ultrasound or CT, MRI found other diseases causing exophthalmos (intraorbital space occupying lesion, inflammatory pseudotumor, neurofibroma, etc.);
uveitis, glaucoma, high myopia, diabetic retinopathy and other eye diseases
those who were considered by the researchers to be excluded
Trial design
Treatments tested in this trial
- modified deep lateral and/or medial wall decompression
Treatment groups
50 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov